Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT03174821

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03174821
Other papers using this trial's data
  • The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy European journal of medical research, 2018-02-12 DOI, PubMed 29433562, PMC5809915 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03174821. Non-randomized; no masking; primary purpose treatment. Start 2010-10-20 (actual); primary completion 2014-05-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy
Condition
Insulin Pump Therapy in Treating Diabetic Nephropathy
Intervention (Device)
Insulin pump
Lead sponsor
Chinese PLA General Hospital (class: other)

Record details

Record id
cardio:ct-nct03174821
Content hash
4e744d5fbfe7994d08100d72f905f8ef970a13f0d304419fd2e3004aae868a22